Aug 12, 2024, 09:21
Giuseppe Banna: RBC-based scores improving prognostic systems in metastatic RCC
Giuseppe Banna, Consultant Medical Oncologist at Portsmouth Hospitals University NHS Trust, recently shared a post on X about a recent paper published in Immunotherapy.
Authors: Shobana Anpalakhan, Giuseppe Luigi Banna, Sara Elena Rebuzzi, Giulia Mazzaschi, Sebastiano Buti et al.
“The potential of RBC-based scores to improve prognostic systems in metastatic renal cell carcinoma. Identifying patients with better prognosis and exploring molecular correlates could refine treatment strategies.
A red blood cell-based score in the prognostication of patients with metastatic RCC of the Meet-URO 15 study: Immunotherapy: Vol 0, No 0 – Get Access.”
Source: Giuseppe Banna/X
More posts by Giuseppe Banna in OncoDaily.
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 7, 2024, 00:18
Nov 7, 2024, 00:04
Nov 6, 2024, 18:17